Benzodiazepines represent a class of psychoactive pharmaceuticals that act as central nervous system depressants by potentiating the effects of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. Pharmacologically, they achieve this effect by enhancing the neurotransmission across the GABA-A receptor complex, thereby increasing the influx of chloride ions into the neuron. This mechanism results in generalized central nervous system depression, which can manifest as sedation, anxiolysis (anxiety reduction), and anticonvulsant properties. The utilization of these compounds is based on modulating inhibitory neurotransmission for therapeutic purposes such as managing generalized anxiety states or treating seizure disorders.